Global Software as a Medical Device (SaMD) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Software as a Medical Device (SaMD) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Software as a Medical Device, or SaMD, can be described as a class of medical software designed to carry out one or more medical functions without the need for actual hardware. This can comprise of software or applications intended to treat diagnose, cure, mitigate or prevent disease. SaMD is typically used with non-medical computing platforms connected to virtual networks or other general-use hardware. Within the general field of healthcare, Software as a Medical Device, or SaMD, is a particularly new category of software resource with a specialized role.

Market Overview:

The latest research study on the global Software as a Medical Device (SaMD) market finds that the global Software as a Medical Device (SaMD) market reached a value of USD 1435.79 million in 2022. It’s expected that the market will achieve USD 10833.99 million by 2028, exhibiting a CAGR of 40.05% during the forecast period.

Region Overview:

In 2021, the share of the Software as a Medical Device (SaMD) market in Americas stood at 46.18%.

Company Overview:

Siemens Healthcare is one of the major players operating in the Software as a Medical Device (SaMD) market, holding a share of 26.02% in 2022.

Siemens Healthcare

Siemens Healthineers is a leading medtech company with over 125 years of experience. Siemens Healthineers' portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways.

Medtronic

Medtronic, Inc. proivdes medical devices. The Company offers surgical devices, medical instruments, apparatus, respiratory monitoring systems, medical supplies, and other equipments. Medtronic serves patients and health care professionals worldwide.

Segmentation Overview:

By type, Class I segment accounted for the largest share of market in 2022.

Application Overview:

The market largest segment by application is the segment Screening and Diagnosis, with a market share of 50.02% in 2022.

Key Companies in the global Software as a Medical Device (SaMD) market covered in Chapter 3:

Viz.AI.
Biofouris
Digital Diagnostics
BrightInsight
Medtronic
Siemens Healthcare
S3 Connected Health
iSchemaView
MindMaze
Arterys

In Chapter 4 and Chapter 14.2, on the basis of types, the Software as a Medical Device (SaMD) market from 2018 to 2029 is primarily split into:

Class I
Class II
Class III
Class IV

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Software as a Medical Device (SaMD) market from 2018 to 2029 covers:

Screening and Diagnosis
Monitoring and Alerting
Chronic Disease Management

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)